Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2023
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancerE C de Heer, C E Zois, E Bridges, et al.
Pathology, Research and Practice|August 10, 2010
Experts and performance in histopathology--a study in breast pathologyD M Parham, N Anderson, I Buley, et al.
HIV Medicine|May 30, 2012
HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortalityM B Klein, K C Rollet, S Saeed, et al.
Psychological Medicine|October 8, 2013
The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) studyR Sprengelmeyer, M Orth, H-P Müller, et al.
Haematologica|April 4, 2024
Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myelomaUmair Munawar, Johanna Theuersbacher, Maximilian J Steinhardt, et al.
Sleep|October 25, 2019
Employer-mandated obstructive sleep apnea treatment and healthcare cost savings among truckersStephen V Burks, Jon E Anderson, Bibhudutta Panda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastomaYaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
Nature Communications|November 5, 2024
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancerM T Herrera-Abreu, J Guan, U Khalid, et al.
Nature Communications|May 2, 2024
Response of treatment-naive brain metastases to stereotactic radiosurgeryChibawanye I Ene, Christina Abi Faraj, Thomas H Beckham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2024
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancerE Harvey-Jones, M Raghunandan, L Robbez-Masson, et al.
Pageof 36